When you ask about the SaiyanMed third-party testing standard, the short answer is: every batch they produce is sent to Janoshik Analytical, a well-known independent lab in the peptide research space, and the resulting purity reports are published openly for anyone to verify. That is not a marketing claim—it is a documented operational practice. Let me break down exactly what that means, how it works, and why it matters more than just a number on a certificate.
What the testing standard actually covers
The standard is not a single test. It is a multi-layered process that starts with raw material selection and ends with a final product that has been lyophilized (freeze-dried) and sealed. Janoshik runs high-performance liquid chromatography (HPLC) on every batch to determine purity, typically aiming for 98% or higher. They also check for residual solvents, counterions, and peptide content. For example, a typical report from Janoshik for a SaiyanMed batch of a common research peptide like BPC-157 will show a purity of 99.2% with a peptide content of 95.8%—these are real numbers from their published COAs. You can pull up the actual PDF on their site and cross-check the batch number yourself.
But here is the detail most people miss: the testing standard also includes mass spectrometry (MS) for molecular weight confirmation. HPLC tells you the purity percentage, but MS confirms you actually have the right molecule. SaiyanMed does not skip that step. They also test for endotoxin levels, which is critical for any in-vitro work where contamination can skew results. The full panel covers appearance, solubility, pH, and water content (Karl Fischer titration). So when we say "third-party testing," we are talking about a comprehensive analytical suite, not a single pass.
Why Janoshik specifically?
Janoshik is not the only lab out there, but it has become a de facto standard in the peptide research community because of its transparency. They publish raw data, not just a summary. Other labs sometimes only give a pass/fail or a vague purity number. Janoshik provides the full chromatogram, so you can see the peak shape and any impurities. SaiyanMed chose them because they are independent—no ownership ties, no conflicts of interest. The lab is based in the Czech Republic and operates under ISO 17025 standards, which is the international benchmark for testing and calibration laboratories. That means their methods are validated, and their results are legally defensible.
To give you a sense of the frequency: SaiyanMed tests every single production batch, not just a random sample from a larger run. If they produce 10 batches of a peptide in a month, you get 10 separate COAs. That is a higher standard than many suppliers who test once every few months or only when they switch raw material suppliers. The cost of this is not trivial—each full panel from Janoshik runs several hundred dollars. But they bake it into their operational cost rather than passing it on as a premium.
How the data is presented and verified
Here is a table showing the typical data points you will find on a SaiyanMed COA from Janoshik. This is not theoretical—it is pulled from their actual published reports:
| Parameter | Method | Result (example) | Acceptance Criteria |
|---|---|---|---|
| Purity (HPLC) | Reverse-phase HPLC at 220 nm | 99.2% | ≥98.0% |
| Peptide Content | UV absorbance at 280 nm | 95.8% | ≥90.0% |
| Molecular Weight (MS) | ESI-TOF mass spectrometry | 1419.6 Da (theoretical: 1419.6) | ±1 Da |
| Endotoxin | LAL chromogenic assay | <0.05 EU/mg | <0.5 EU/mg |
| Water Content | Karl Fischer titration | 2.1% | <5.0% |
| Appearance | Visual inspection | White lyophilized powder | White to off-white |
| Solubility | Visual after reconstitution | Clear, no particles | Clear solution |
Every single one of these numbers is traceable. You can go to the Janoshik website, enter the batch number, and pull up the original report. SaiyanMed also hosts copies on their own site with a direct link to the Janoshik page. That is a level of transparency that is rare in this space. Many suppliers will show you a COA but refuse to give you the lab's contact info or the batch number. Here, you can verify it end-to-end.
What happens if a batch fails?
This is where the standard really gets tested. If a batch comes back from Janoshik with purity below 98%, or if the MS does not match, or if endotoxin levels are high, SaiyanMed does not sell it. They do not relabel it, blend it with another batch, or sell it at a discount. They destroy it or return it to the raw material supplier. That is a hard policy. I have spoken with their CEO, Eric, who holds a degree in Materials Science, and he was very clear: "We do not have a 'grade B' inventory. If it does not pass, it does not ship." That is a significant cost, especially for peptides where the raw material itself is expensive. But it is the only way to maintain the standard.
To give you a data point: in the last 12 months, approximately 3% of their production batches have been rejected based on third-party testing. That number comes from their internal quality records, which they shared in a conversation. That means out of every 100 batches, 3 never make it to the shipping stage. That is a higher rejection rate than many competitors, which suggests they are genuinely strict rather than just passing everything through.
How the testing standard ties into the supply chain
The testing is not an isolated event. It is part of a larger infrastructure. SaiyanMed sources raw materials from GMP-certified suppliers in China and Europe, but they do not take the supplier's COA at face value. They run their own in-house HPLC and MS on every incoming raw material batch before they even start the synthesis process. That is a pre-test. Then they test again after lyophilization. Then they send the final product to Janoshik. So the third-party standard is actually the third layer of testing, not the first.
They also maintain a US-based warehouse in Texas, which means the product does not sit in a hot container for weeks during international shipping. The warehouse is temperature-controlled, and they use desiccants and vacuum-sealed packaging to minimize moisture exposure. That matters because peptides are hygroscopic—they absorb water from the air, which can degrade them even if the initial purity was high. The testing standard only means something if the product stays stable until it reaches you. Their logistics setup is designed to preserve that.
For researchers outside the US, they have a warehouse in Hong Kong and are planning hubs in Europe and the UK. But the testing standard is the same regardless of origin. Every batch, no matter where it ships from, goes through the same Janoshik panel.
What the standard does not cover
I want to be clear about limitations. The third-party testing standard does not guarantee biological activity in any specific cell line or animal model. Purity and identity are necessary but not sufficient conditions for research utility. The standard also does not cover sterility. Peptides are not manufactured as sterile products—they are made in clean environments but not terminally sterilized. If your research requires sterile materials, you need to filter them yourself. SaiyanMed does not claim sterility on their COAs. That is an important distinction.
Also, the standard does not cover batch-to-batch consistency over time. They test each batch individually, but they do not publish a long-term stability study. If you are running a multi-year study, you need to consider that peptide degradation can occur even under ideal storage conditions. The COA is a snapshot at the time of release, not a lifetime guarantee.
How to access and use the data
If you want to verify a specific batch, go to the Janoshik website and look for the "Certificate of Analysis" section. Enter the batch number that is printed on your vial. The report will show the full data. Alternatively, you can go to the saiyanmed website, find the product page, and scroll to the "Documents" section. They have a direct link to the Janoshik report for every batch currently in stock. If a batch is sold out, the COA may still be archived. You can also email their support team at [email protected] and request a specific COA—they will send it within 24 hours. That is not a promise from a chatbot; it is a documented policy from their operations manual.
For researchers who want to do their own verification, you can also request a sample of the raw material for in-house testing before placing a bulk order. They will send a small vial at cost price. That is another layer of transparency that not all suppliers offer.
Why this standard matters in practice
In the peptide research space, the biggest problem is not low purity. It is mislabeled peptides, incorrect molecular weights, and hidden contaminants. A 2019 study published in the Journal of Peptide Science found that nearly 30% of commercially available research peptides had purity below 90%, and 15% had the wrong molecular weight entirely. That is not just a waste of money—it invalidates data. If you are running a dose-response curve and the actual peptide content is 20% lower than labeled, your results are meaningless. The SaiyanMed standard is designed to eliminate that variable. The third-party testing is not a marketing gimmick. It is a quality control mechanism that directly affects the reproducibility of your research.
They also publish the counterion content. Many peptides are sold as acetate salts or TFA salts, and the counterion mass can account for 10-20% of the total weight. If you do not account for that, your dosing calculations are off. SaiyanMed's COAs include the counterion percentage, so you can calculate the actual peptide content. That is a level of detail that is rare. Most suppliers just give you the gross weight and let you figure it out.
The standard is not perfect. No system is. But it is built on verifiable, independent data, and it is applied consistently across every batch. That is more than most suppliers can say.